FindTrial
Sign In

ENLARGEMENT OF MALE BREAST: OUTCOME OF MEDICAL AND SURGICAL MANAGEMENT

INVESTIGATION OF CLINICAL TYPES, HORMONAL PROFILE AND TREATMENT OUTCOMES IN PATIENTS WITH GYNECOMASTIA

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2015/01/005440
Enrollment
30
Registered
2015-01-22
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Two stage subcutaneous mastectomy: Patients will undergo subcutaneous mastectomy of upper half of the enlarged breast on first sitting, followed three months later by that of lower half

Sponsors

AIIMS
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients coming to surgical/ endocrinology OPD with the diagnosis of gynecomastia.

Exclusion criteria

Exclusion criteria: 1. Patients who are unwilling or unable to provide informed consent. 2. Patients who have contraindications to tamoxifen therapy viz history of thromboembolism, stroke, and coronary artery disease.

Design outcomes

Primary

MeasureTime frame
Cosmesis scoreTimepoint: 6 months from surgery—

Secondary

MeasureTime frame
Surgical complicationsTimepoint: Withing 6 months of surgery—

Countries

India

Contacts

Public ContactSubash Lohani

AIIMS

drmaneesh@gmail.com9868397713

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026